Table 3.
Participant demographic and clinical characteristics at baseline.
| Characteristics | eMotion | Control Group | Whole Sample | |||
|
|
N | n (%) | N | n (%) | N | n (%) |
| Female | 32 | 26 (81) | 30 | 26 (87) | 62 | 52 (84) |
| Receiving therapy | 32 | 1 (3) | 30 | 7 (23) | 62 | 8 (13) |
| Antidepressants | 32 | 18 (56) | 30 | 18 (60) | 62 | 36 (58) |
| >150 m per week of MVPAa (10-min bouts) | 27 | 3 (11) | 25 | 4 (16) | 52 | 7 (13) |
| Currently employed, studying, or training | 32 | 28 (88) | 30 | 27 (90) | 62 | 55 (89) |
| Educated to A level or beyond | 32 | 25 (78) | 30 | 23 (77) | 62 | 48 (77) |
aMVPA: moderate-to-vigorous intensity physical activity.